Aryeh Jason 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Aryeh Jason（CIK 1376960）在 3 家公司共报告 15 笔 SEC Form 4 内部人交易（最近一笔 2026-06-12）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-12 | LIGAND PHARMACEUTICALS INC (LGND) | 董事 | 卖出 | 500 | $125,000 |
| 2026-06-12 | LIGAND PHARMACEUTICALS INC (LGND) | 董事 | 卖出 | 4,500 | $1.1M |
| 2026-06-12 | LIGAND PHARMACEUTICALS INC (LGND) | 董事 | 买入 | 836 | $0 |
| 2026-06-05 | LIFECORE BIOMEDICAL, INC. DE (LFCR) | 董事 | 买入 | 25,907 | $0 |
| 2026-05-20 | Orchestra BioMed Holdings, Inc. (OBIO) | 董事 | 买入 | 665 | $2,494 |
| 2026-05-19 | Orchestra BioMed Holdings, Inc. (OBIO) | 董事 | 买入 | 8,971 | $34,987 |
| 2025-12-08 | LIGAND PHARMACEUTICALS INC (LGND) | 董事 | 买入 | 2,034 | $141,383 |
| 2025-09-24 | LIGAND PHARMACEUTICALS INC (LGND) | 董事 | 卖出 | 4,418 | $752,871 |
| 2025-09-24 | LIGAND PHARMACEUTICALS INC (LGND) | 董事 | 卖出 | 4,628 | $791,203 |
| 2025-09-24 | LIGAND PHARMACEUTICALS INC (LGND) | 董事 | 卖出 | 954 | $164,012 |
| 2025-09-19 | Orchestra BioMed Holdings, Inc. (OBIO) | 董事 | 买入 | 1,000 | $2,450 |
| 2025-08-08 | Orchestra BioMed Holdings, Inc. (OBIO) | 董事 | 买入 | 15,000 | $0 |
| 2025-07-17 | LIFECORE BIOMEDICAL, INC. DE (LFCR) | 董事 | 买入 | 19,506 | $0 |
| 2025-06-27 | Orchestra BioMed Holdings, Inc. (OBIO) | 董事 | 买入 | 12,422 | $0 |
| 2025-06-10 | LIGAND PHARMACEUTICALS INC (LGND) | 董事 | 买入 | 1,209 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-12